Patents by Inventor Abdoulaye Sene

Abdoulaye Sene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MOTOR VEHICLE PARKING ASSIST METHOD AND SYSTEM
    Publication number: 20200023833
    Abstract: A motor vehicle parking assist system is for parking the vehicle moving from a traffic lane towards a vacant parking space and leaving the parking space to move towards the traffic lane. The parking assist system includes a module for determining the vehicle acceleration, which module is suitable for delivering a set point value for acceleration depending on the vehicle speed and on the distance from an obstacle and a torque regulating module suitable for calculating a set point value for braking torque and a set point value for engine torque depending on the set point value for acceleration, the vehicle speed, and for the road gradient.
    Type: Application
    Filed: March 8, 2018
    Publication date: January 23, 2020
    Applicant: RENAULT s.a.s.
    Inventors: Guillaume MARTIN, Pape Abdoulaye SENE, Sebastien SALIOU
  • Non Human Animal Models for Increased Retinal Vascular Permeability
    Publication number: 20140186960
    Abstract: The present invention relates to a non human animal model for increased retinal vascular permeability wherein said increased retinal vascular permeability is induced by inhibiting in Müller cells of said animal the expression of a gene encoding for Dp71 or a dystrophin associated protein (DAP). Furthermore, the present invention relates to methods and compositions for the treatment of a disease associated with an increased retinal vascular permeability in a subject in need thereof.
    Type: Application
    Filed: February 7, 2014
    Publication date: July 3, 2014
    Applicant: Institut National De La Sante et De La Recherche Medicale (INSERM)
    Inventors: Abdoulaye Sene, Ramin Tadayoni, Jose Sahel, Alvaro Rendon
  • Methods for modulating angiogenesis via dystrophin Dp71
    Patent number: 8603964
    Abstract: The present invention relates to methods and compositions for inhibiting or stimulating angiogenesis. The invention shows the implication of Dp71 in angiogenesis and thus provides novel therapeutic approaches, as well as novel methods for screening agents modulating angiogenesis, which target this protein. More specifically, the present invention relates to the use of Dp71 or a variant thereof (or a coding nucleic acid) for stimulating angiogenesis in a subject, particularly a human subject. The invention relates to the use of an inhibitor of Dp71 for inhibiting angiogenesis in a subject.
    Type: Grant
    Filed: July 3, 2009
    Date of Patent: December 10, 2013
    Assignee: Institut National de la Sante et de la Recherche Medicale (Inserm)
    Inventors: Romain Bernard, Bénédicte Dupas, Alain Gaudric, Serge Picaud, Alvaro Rendon, José-Alain Sahel, Abdoulaye Sene, Florian Sennlaub, Ramin Tadayoni, Eric Vicaut
  • NON HUMAN ANIMAL MODELS FOR INCREASED RETINAL VASCULAR PERMEABILITY
    Publication number: 20120142609
    Abstract: The present invention relates to a non human animal model for increased retinal vascular permeability wherein said increased retinal vascular permeability is induced by inhibiting in Müller cells of said animal the expression of a gene encoding for Dp71 or a dystrophin associated protein (DAP). Furthermore, the present invention relates to methods and compositions for the treatment of a disease associated with an increased retinal vascular permeability in a subject in need thereof.
    Type: Application
    Filed: June 25, 2010
    Publication date: June 7, 2012
    Inventors: Abdoulaye Sene, Ramin Tadayoni, Jose Sahel, Alvaro Rendon
  • METHODS FOR MODULATING ANGIOGENESIS VIA DYSTROPHIN DP71
    Publication number: 20110183890
    Abstract: The present invention relates to methods and compositions for inhibiting or stimulating angiogenesis. The invention shows the implication of Dp71 in angiogenesis and thus provides novel therapeutic approaches, as well as novel methods for screening agents modulating angiogenesis, which target this protein. More specifically, the present invention relates to the use of Dp71 or a variant thereof (or a coding nucleic acid) for stimulating angiogenesis in a subject, particularly a human subject. The invention relates to the use of an inhibitor of Dp71 for inhibiting angiogenesis in a subject.
    Type: Application
    Filed: July 3, 2009
    Publication date: July 28, 2011
    Inventors: Romain Bernard, Bénédicte Dupas, Alain Gaudric, Serge Picaud, Alvaro Rendon, José-Alain Sahel, Abdoulaye Sene, Florian Sennlaub, Ramin Tadayoni, Eric Vicaut